| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | SELL | BUY | NEUTRAL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 1.50▼ | 1.50▼ | 1.50▼ | 1.42▲ | 1.52▼ |
| MA10 | 1.51▼ | 1.48▼ | 1.46▲ | 1.46▲ | 1.51▼ |
| MA20 | 1.50▼ | 1.44▲ | 1.42▲ | 1.53▼ | 1.48▼ |
| MA50 | 1.44▲ | 1.47▼ | 1.46▲ | 1.51▼ | 1.41▲ |
| MA100 | 1.48▼ | 1.50▼ | 1.53▼ | 1.44▲ | 1.44▲ |
| MA200 | 1.52▼ | 1.59▼ | 1.57▼ | 1.38▲ | 1.69▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | -0.006▼ | 0.008▲ | 0.013▲ | -0.016▼ | -0.001▼ |
| RSI | 42.479▼ | 51.939▲ | 52.592▲ | 46.552▼ | 50.696▲ |
| STOCH | 8.333▼ | 79.715 | 83.186▲ | 32.182 | 56.216 |
| WILL %R | -100.000▼ | -42.308 | -34.375 | -46.154 | -57.115 |
| CCI | -304.889▼ | -4.996 | 40.753 | -4.610 | -10.530 |
|
Monday, August 18, 2025 04:41 AM
August 18, 2025 / NanoViricides, Inc., a publicly traded company (NYSE American:NNVC) (the "Company"), and a clinical stage, leading global pioneer in the development of broad-spectrum antivirals ...
|
|
Tuesday, August 05, 2025 03:57 PM
By David Bautz, PhD NYSE:NNVC NanoViricides, Inc. (NYSE:NNVC) is a clinical-stage biopharmaceutical company developing a new class of broad-spectrum antiviral drugs known as “nanoviricides”.
|
|
Monday, July 28, 2025 06:18 AM
Discover real-time NanoViricides, Inc. Common Stock (NNVC) stock prices, quotes, historical data, news, and Insights for informed trading and investment decisions. Stay ahead with Nasdaq.
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 25/08/25 | 1.54 | 1.54 | 1.4609 | 1.48 | 254,587 |
| 22/08/25 | 1.38 | 1.45 | 1.37 | 1.44 | 109,800 |
| 21/08/25 | 1.35 | 1.39 | 1.35 | 1.37 | 37,749 |
| 20/08/25 | 1.42 | 1.42 | 1.34 | 1.37 | 143,200 |
| 19/08/25 | 1.57 | 1.57 | 1.435 | 1.44 | 178,231 |
| 18/08/25 | 1.52 | 1.56 | 1.51 | 1.53 | 278,796 |
| 15/08/25 | 1.49 | 1.51 | 1.44 | 1.50 | 119,900 |
| 14/08/25 | 1.50 | 1.5075 | 1.43 | 1.47 | 102,738 |
| 13/08/25 | 1.54 | 1.54 | 1.48 | 1.50 | 181,100 |
| 12/08/25 | 1.56 | 1.56 | 1.51 | 1.54 | 103,800 |
|
|
||||
|
|
||||
|
|